CollPlant Biotechnologies (CLGN) Non-cash Items (2018 - 2021)
CollPlant Biotechnologies' (CLGN) quarterly Non-cash Items came in at -$2.5 million in Q3 2021, down 374.73% YoY from $918000.0 in Q3 2020, and down 7.78% on a QoQ basis from -$2.3 million in Q2 2021.
CollPlant Biotechnologies (CLGN) Non-cash Items (2018 - 2021) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 4 years of Non-cash Items data on file, last reported at -$2.5 million in Q3 2021.
- Quarterly Non-cash Items fell 374.73% year-over-year to -$2.5 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $4.0 million (up 210.63% YoY) and the FY2020 annual result came in at -$3.3 million, up 44.08% from the prior year.
- Non-cash Items retreated to -$2.5 million in Q3 2021, from -$2.3 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $10.6 million in Q1 2021 to a low of -$2.5 million in Q3 2021.
- A 4-year average of -$396266.7 and a median of -$1.2 million in 2018 frame the typical range for Non-cash Items.
- The widest YoY moves for Non-cash Items: up 864.04% in 2021, down 374.73% in 2021.
- Tracing CLGN's Non-cash Items over 4 years: stood at $1.0 million in 2018, then sank by 298.8% to -$2.0 million in 2019, then gained by 13.38% to -$1.7 million in 2020, then plunged by 46.46% to -$2.5 million in 2021.
- The last three Non-cash Items figures came in at -$2.5 million (Q3 2021), -$2.3 million (Q2 2021), and $10.6 million (Q1 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | CollPlant Biotechnologies | 4.23 Mn | 4.23 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -2.52 Mn |
| Sep 30, 2021 | -2.52 Mn |
| Jun 30, 2021 | -2.34 Mn |
| Jun 30, 2021 | -2.34 Mn |
| Mar 31, 2021 | 10.56 Mn |
| Mar 31, 2021 | 10.56 Mn |
| Dec 31, 2020 | -1.72 Mn |
| Dec 31, 2020 | -1.72 Mn |
| Sep 30, 2020 | 918,000.00 |
| Sep 30, 2020 | 918,000.00 |
| Jun 30, 2020 | -1.14 Mn |
| Jun 30, 2020 | -1.14 Mn |
| Mar 31, 2020 | -1.38 Mn |
| Mar 31, 2020 | -1.38 Mn |
| Dec 31, 2019 | -1.99 Mn |
| Dec 31, 2019 | -1.99 Mn |
| Sep 30, 2019 | -1.63 Mn |
| Sep 30, 2019 | -1.63 Mn |
| Jun 30, 2019 | -1.32 Mn |
| Jun 30, 2019 | -1.32 Mn |